More News related to Special Reports XL Capital Ltd. (NYSE: XL) 41.2% LOWER; continues to plunge on worries in the insurance sector. The stock is down 70% over the past 5 days. Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI) 37.5% LOWER; announced that the Fibrin Pad U.S. Phase II clinical trial in mild to moderate bleeding was suspended yesterday afternoon to investigate an incident of post-operative bleeding. The Company will provide an update once additional information is available. Horace Mann Educators (NYSE: HMN) 36.5% LOWER; yesterday's announcement that the government would give AIG an extra $38 billion loan sent a shiver through the entire insurance sector as traders are considering if more capital raises will be needed throughout the sector. Advanced Medical Optics,...
[read full story]